James S Scibetta

CIK 1383242 · View on SEC EDGAR ↗

Insider

First SEC filing: July 24, 2018 · Latest: July 24, 2018

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 49 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

49 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
Aug. 21, 2019 AQST P 900 $3.81 $3,429 31,635 Direct +2.93% Acquired 19.4% (price as of 2026-08-20)
Aug. 20, 2019 AQST P 11,310 $3.80 $42,978 30,735 Direct +58.22% Acquired 19.7% (price as of 2026-08-20)
Aug. 19, 2019 AQST P 10,761 $3.77 $40,569 19,425 Direct +124.20% Acquired 20.7% (price as of 2026-08-20)
June 5, 2017 PCRX S 1,966 $43.32 $85,167 25,118 Direct -7.26% Disposed -44.4% (price as of 2026-08-20)
May 15, 2017 PCRX S 10b5-1 20,000 $51.20 $1,024,000 27,084 Direct -42.48% Disposed -53.0% (price as of 2026-08-20)
Jan. 17, 2017 PCRX S 10b5-1 4,997 $38.97 $194,733 27,084 Direct -15.58% Disposed -38.2% (price as of 2026-08-20)
Jan. 17, 2017 PCRX S 10b5-1 15,003 $38.39 $575,965 32,081 Direct -31.86% Disposed -37.3% (price as of 2026-08-20)
Nov. 15, 2016 PCRX S 10b5-1 20,000 $36.50 $730,000 27,084 Direct -42.48% Disposed -34.0% (price as of 2026-08-20)
Aug. 15, 2016 PCRX S 10b5-1 25,000 $45.21 $1,130,250 27,084 Direct -48.00% Disposed -46.7% (price as of 2026-08-20)
Sept. 11, 2015 PCRX P 5,000 $61.37 $306,850 10,504 Direct +90.84% Acquired -60.8% (price as of 2026-08-20)
Feb. 6, 2015 PCRX S 10b5-1 1,700 $112.91 $191,947 5,230 Direct -24.53% Disposed -78.7% (price as of 2026-08-20)
Feb. 6, 2015 PCRX S 10b5-1 3,103 $111.98 $347,474 6,930 Direct -30.93% Disposed -78.5% (price as of 2026-08-20)
Feb. 6, 2015 PCRX S 10b5-1 5,904 $111.11 $655,993 10,033 Direct -37.05% Disposed -78.3% (price as of 2026-08-20)
Feb. 6, 2015 PCRX S 10b5-1 4,293 $110.17 $472,960 15,937 Direct -21.22% Disposed -78.1% (price as of 2026-08-20)
Nov. 7, 2014 PCRX S 10b5-1 200 $90.33 $18,066 5,000 Direct -3.85% Disposed -73.3% (price as of 2026-08-20)
Nov. 7, 2014 PCRX S 10b5-1 800 $89.56 $71,648 5,200 Direct -13.33% Disposed -73.1% (price as of 2026-08-20)
Nov. 7, 2014 PCRX S 10b5-1 3,100 $87.65 $271,715 6,000 Direct -34.07% Disposed -72.5% (price as of 2026-08-20)
Nov. 7, 2014 PCRX S 10b5-1 8,600 $86.99 $748,114 9,100 Direct -48.59% Disposed -72.3% (price as of 2026-08-20)
Nov. 7, 2014 PCRX S 10b5-1 2,300 $86.13 $198,099 17,700 Direct -11.50% Disposed -72.0% (price as of 2026-08-20)
Aug. 8, 2014 PCRX S 10b5-1 10,000 $99.83 $998,300 5,000 Direct -66.67% Disposed -75.9% (price as of 2026-08-20)
Aug. 8, 2014 PCRX S 10b5-1 5,000 $99.22 $496,100 15,000 Direct -25.00% Disposed -75.7% (price as of 2026-08-20)
May 8, 2014 PCRX S 10b5-1 300 $75.80 $22,740 5,000 Direct -5.66% Disposed -68.2% (price as of 2026-08-20)
May 8, 2014 PCRX S 10b5-1 11,400 $75.25 $857,850 5,300 Direct -68.26% Disposed -68.0% (price as of 2026-08-20)
May 8, 2014 PCRX S 10b5-1 3,300 $74.27 $245,091 16,700 Direct -16.50% Disposed -67.6% (price as of 2026-08-20)
Dec. 30, 2013 PCRX S 10b5-1 10,000 $55.55 $555,500 5,000 Direct -66.67% Disposed -56.6% (price as of 2026-08-20)
Sept. 30, 2013 PCRX S 10b5-1 10,000 $46.74 $467,400 5,000 Direct -66.67% Disposed -48.5% (price as of 2026-08-20)
June 28, 2013 PCRX S 10b5-1 10,000 $28.05 $280,500 5,000 Direct -66.67% Disposed -14.1% (price as of 2026-08-20)
March 28, 2013 PCRX S 10b5-1 10,000 $28.49 $284,900 5,000 Direct -66.67% Disposed -15.5% (price as of 2026-08-20)
Feb. 15, 2011 PCRX P 5,000 $7.04 $35,200 5,000 Direct — Acquired 242.1% (price as of 2026-08-20)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
June 15, 2021 AQST Stock Option (Right to Purchase) Common Stock (20,000) $4.04 June 15, 2031 20,000 Acquired
June 16, 2020 AQST Stock Option (Right to Purchase) Common Stock (14,000) $5.30 June 16, 2030 14,000 Acquired
June 13, 2019 AQST Stock Option (Right to Purchase) Common Stock (13,350) $4.38 June 13, 2029 13,350 Acquired
July 24, 2018 AQST Stock Option (Right to Purchase) Common Stock (26,700) $15.00 July 24, 2028 26,700 Acquired
May 15, 2017 PCRX Stock Option (Right to Buy) Common Stock (20,000) $5.49 Dec. 29, 2020 20,000 Disposed
Jan. 17, 2017 PCRX Stock Option (Right to Buy) Common Stock (17,627) $5.49 Dec. 29, 2020 17,627 Disposed
Jan. 17, 2017 PCRX Stock Option (Right to Buy) Common Stock (2,373) $1.61 Sept. 2, 2020 2,373 Disposed
Dec. 7, 2016 PCRX Stock Option (Right to Buy) Common Stock (20,000) $32.35 Dec. 7, 2026 20,000 Acquired
Nov. 15, 2016 PCRX Stock Option (Right to Buy) Common Stock (20,000) $1.61 Sept. 2, 2020 20,000 Disposed
Aug. 15, 2016 PCRX Stock Option (Right to Buy) Common Stock (9,123) $1.61 Sept. 2, 2020 9,123 Disposed
Aug. 15, 2016 PCRX Stock Option (Right to Buy) Common Stock (15,877) $1.61 Sept. 2, 2020 15,877 Disposed
June 15, 2016 PCRX Stock Option (Right to Buy) Common Stock (32,500) $40.34 June 15, 2026 32,500 Acquired
Nov. 3, 2015 PCRX Stock Option (Right to Buy) Common Stock (40,000) $55.34 Nov. 3, 2025 40,000 Acquired
Feb. 6, 2015 PCRX Stock Option (Right to Buy) Common Stock (15,000) $1.61 Sept. 2, 2020 15,000 Disposed
Nov. 7, 2014 PCRX Stock Option (Right to Buy) Common Stock (15,000) $1.61 Sept. 2, 2020 15,000 Disposed
Aug. 8, 2014 PCRX Stock Option (Right to Buy) Common Stock (6,134) $1.61 Sept. 2, 2020 6,134 Disposed
Aug. 8, 2014 PCRX Stock Option (Right to Buy) Common Stock (8,866) $1.61 Sept. 2, 2020 8,866 Disposed
June 3, 2014 PCRX Stock Option (Right to Buy) Common Stock (70,000) $81.00 June 3, 2024 70,000 Acquired
May 8, 2014 PCRX Employee Stock Option (right to buy) Common Stock (15,000) $1.61 Sept. 2, 2020 15,000 Disposed
Dec. 31, 2013 NEPH Non-Qualified Stock Option (right to buy) Common Stock (60,440) $0.42 Dec. 31, 2023 60,440 Acquired
Dec. 30, 2013 PCRX Employee Stock Option (right to buy) Common Stock (10,000) $1.61 Sept. 2, 2020 10,000 Disposed
Sept. 30, 2013 PCRX Employee Stock Option (right to buy) Common Stock (10,000) $1.61 Sept. 2, 2020 10,000 Disposed
June 28, 2013 PCRX Employee Stock Option (right to buy) Common Stock (10,000) $1.61 Sept. 2, 2020 10,000 Disposed
May 23, 2013 NEPH Non-Qualified Stock Option (right to buy) Common Stock (12,500) $0.71 May 23, 2023 12,500 Acquired
March 28, 2013 PCRX Employee Stock Option (right to buy) Common Stock (10,000) $1.61 Sept. 2, 2020 10,000 Disposed
June 5, 2012 PCRX Common Stock Common Stock (150,000) $10.81 June 4, 2022 150,000 Acquired
Feb. 16, 2012 NEPH Non-Qualified Stock Option (right to buy) Common Stock (12,500) $0.83 Feb. 16, 2022 12,500 Acquired
March 24, 2011 NEPH Non-qualified stock option (right to buy) Common Stock (60,000) $0.51 March 24, 2021 60,000 Acquired
Jan. 8, 2010 NEPH Non-qualified stock option (right to buy) Common Stock (22,500) $0.95 Jan. 8, 2020 22,500 Acquired
Aug. 17, 2009 NEPH Non-qualified stock option (right to buy) Common Stock (20,000) $1.71 Aug. 17, 2019 20,000 Acquired
Nov. 30, 2007 NEPH Non-qualified stock option (right to buy) Common Stock (20,000) $0.80 Nov. 30, 2017 20,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 4 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
July 24, 2018 AQST Common Stock [F1] 8,664 Direct
Feb. 2, 2011 PCRX Stock Option (Right to Buy)→ Common Stock (74,384) 74,384 Direct
Feb. 2, 2011 PCRX Stock Option (Right to Buy)→ Common Stock (72,989) 72,989 Direct
Feb. 2, 2011 PCRX Stock Option (Right to Buy)→ Common Stock (52,877) 52,877 Direct

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

PCRX

Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2016 $494,231 $198,000 $655,525 $980,572 — — $966 $2,329,294
2015 $409,091 $237,500 — $1,091,868 — — $966 $1,739,425
2014 $369,253 $165,000 — $2,980,099 — — $966 $3,515,318

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.